Ben Bronstein - 07 Jun 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Ben Bronstein
Issuer symbol
ALDX
Transactions as of
07 Jun 2022
Transactions value $
$0
Form type
4
Filing time
09 Jun 2022, 17:06:12 UTC
Previous filing
10 Jun 2021
Next filing
29 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +53.8K $0.00 53.8K 07 Jun 2022 Common Stock 53.8K $3.60 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +3.48K $0.00 3.48K 07 Jun 2022 Common Stock 3.48K $3.60 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +3.71K $0.00 3.71K 07 Jun 2022 Common Stock 3.71K $3.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.